IA
LUCD icon

IFP Advisors’s Lucid Diagnostics LUCD Stock Holding History

IFP Advisors’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$168 Buy
157
+120
+324% +$129 ﹤0.01% 4882
2026
Q1 		$43 Buy
37
+9
+32% +$11 ﹤0.01% 4848
2025
Q4 		$31 Sell
28
-355
-93% -$397 ﹤0.01% 4762
2025
Q3 		$387 Buy
+383
New +$418 ﹤0.01% 4249

Other funds holding LUCD

Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

IFP Advisors's LUCD Position: Q2 2026 in Review

IFP Advisors increased its Lucid Diagnostics (LUCD) stake by 324% in Q2 2026, buying an estimated $129 and bringing the position to 157 shares worth $168. The position accounts for ﹤0.01% of the portfolio, ranked #4882.

IFP Advisors first reported a position in LUCD in Q3 2025 and has held it in 4 quarters since. The position peaked at $387 in Q3 2025. 116 funds tracked by Wall St. Rank hold LUCD as of Q2 2026.

  • IFP Advisors held 157 shares of Lucid Diagnostics worth $168 as of Q2 2026.
  • IFP Advisors bought 120 Lucid Diagnostics shares in Q2 2026, an estimated $129.
  • Lucid Diagnostics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4882 holding.
  • IFP Advisors first reported a position in Lucid Diagnostics in Q3 2025 and has held it in 4 quarters since.
  • IFP Advisors's Lucid Diagnostics position peaked at $387 in Q3 2025.
  • 116 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.